recent publications
-
academic article
- Firstenberg, M. S., Dyke, C. M., Angiolillo, D. J., Ramaiahm, C., Price, M., Brtko, M., Welsby, I., Chandna, H., Holmes, D. R., Voeltz, M., Tummala, P., Hutyra, M., et al. Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery Heart Surgery Forum 2013 16:E60-E69 DOI:10.1532/hsf98.20121103 PMID:23625478
- Price, M. J., Murray, S. S., Angiolillo, D. J., Lillie, E., Smith, E. N., Tisch, R. L., Schork, N. J., Teirstein, P. S., Topol, E. J., Investigators, Gift Influence of genetic polymorphisms on the effect of high-and standard-dose clopidogrel after percutaneous coronary intervention the gift (genotype information and functional testing) study Journal of the American College of Cardiology 2012 59:1928-1937 DOI:10.1016/j.jacc.2011.11.068 PMID:22624833
- Angiolillo, D. J., Firstenberg, M. S., Price, M. J., Tummala, P. E., Hutyra, M., Welsby, I. J., Voeltz, M. D., Chandna, H., Ramaiah, C., Brtko, M., Cannon, L., Dyke, C., et al. Bridging antiplatelet therapy with cangrelor in patients undergoing cardiac surgery a randomized controlled trial JAMA-Journal of the American Medical Association 2012 307:265-274 DOI:10.1001/jama.2011.2002 PMID:22253393 PMCID:PMC3774162
- Price, M. J., Angiolillo, D. J., Teirstein, P. S., Lillie, E., Manoukian, S. V., Berger, P. B., Tanguay, J. F., Cannon, C. P., Topol, E. J. Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention a time-dependent analysis of the gauging responsiveness with a verifynow p2y12 assay: Impact on thrombosis and safety (gravitas) trial Circulation 2011 124:1132-1137 DOI:10.1161/circulationaha.111.029165 PMID:21875913
- Price, M. J., Berger, P. B., Teirstein, P. S., Tanguay, J. F., Angiolillo, D. J., Spriggs, D., Puri, S., Robbins, M., Garratt, K. N., Bertrand, O. F., Stillablower, M. E., Aragon, J. R., et al. Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial JAMA-Journal of the American Medical Association 2011 305:1087-1095 DOI:10.1001/jama.2011.290 PMID:21406646
- Price, M. J., Berger, P. B., Angiolillo, D. J., Teirstein, P. S., Tanguay, J. F., Kandzari, D. E., Cannon, C. P., Topol, E. J. Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: Design and rationale of the gravitas trial American Heart Journal 2009 157:818-824 DOI:10.1016/j.ahj.2009.02.012 PMID:19376306